A report on NANB Hepatitis was prepared for the ACVSB. It described the issue of surrogate testing for NANBH as being "of some urgency" and suggested that it be a major item for the next meeting. Read more about A report on NANB Hepatitis was prepared for the ACVSB. It described the issue of surrogate testing for NANBH as being "of some urgency" and suggested that it be a major item for the next meeting.
Journal article titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' described chronic NANBH as symptomatically mild and unaccompanied by physical signs or laboratory evidence of autoimmune disease or severe chronic liver disease.. Read more about Journal article titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' described chronic NANBH as symptomatically mild and unaccompanied by physical signs or laboratory evidence of autoimmune disease or severe chronic liver disease..
A study from Canada, published in the Lancet, found that 70 percent of hepatitis C infections would have been avoided by the use of the two surrogate markers, ALT and anti HBc. Read more about A study from Canada, published in the Lancet, found that 70 percent of hepatitis C infections would have been avoided by the use of the two surrogate markers, ALT and anti HBc.
Alter et al wrote in the New England Journal of Medicine that 'surrogate assays for anti-HBc and alanine aminotransferase would have detected approximately half the anti-HCV-positive donors involved in the transmission of hepatitis they had identified. Read more about Alter et al wrote in the New England Journal of Medicine that 'surrogate assays for anti-HBc and alanine aminotransferase would have detected approximately half the anti-HCV-positive donors involved in the transmission of hepatitis they had identified.
In a written submission to the Inquiry, SNBTS stated that they have on balance reached the conclusion that surrogate testing for NANBH should have been introduced. Read more about In a written submission to the Inquiry, SNBTS stated that they have on balance reached the conclusion that surrogate testing for NANBH should have been introduced.
In his written statement, Professor John Gillon noted that there was no doubt that screening with one or both of the the ALT or anti-HBc screening tests would have prevented some cases of NANBH, and in spite of the lack of data on the incidence of PTNANBH this would have been a desirable outcome. Read more about In his written statement, Professor John Gillon noted that there was no doubt that screening with one or both of the the ALT or anti-HBc screening tests would have prevented some cases of NANBH, and in spite of the lack of data on the incidence of PTNANBH this would have been a desirable outcome.
A study by Ware et al titled 'Etiology of liver disease in renal transplant patients' reported that infection with NANBH accounted for much of serious, often fatal, complications of renal transplantation. Read more about A study by Ware et al titled 'Etiology of liver disease in renal transplant patients' reported that infection with NANBH accounted for much of serious, often fatal, complications of renal transplantation.
Alter et al published a paper titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' in the Annals of Internal Medicine journal. Read more about Alter et al published a paper titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' in the Annals of Internal Medicine journal.
Dr Kernoff wrote to Dr Colvin describing Non-A Non-B Hepatitis as "a serious disease with long-term consequences". Read more about Dr Kernoff wrote to Dr Colvin describing Non-A Non-B Hepatitis as "a serious disease with long-term consequences".
A report for a multi-centre study on Non-A Non-B Hepatitis surrogate screening was completed. Read more about A report for a multi-centre study on Non-A Non-B Hepatitis surrogate screening was completed.